Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.

Authors
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 1 Department of Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA.
  • 2 Department of Medicine, Jane Anne Nohl Division of Hematology, University of Southern California, Los Angeles, California 90089, USA.
  • 3 Department of Pediatrics, Division of Hematology/Oncology, Washington University, St Louis, Missouri 63110, USA.
  • 4 The Genome Institute, Washington University, St Louis, Missouri 63110, USA.
  • 5 Department of Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA.
  • 6 1] Department of Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA [2] Siteman Cancer Center, Washington University, St Louis, Missouri 63110, USA.
  • 7 Department of Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA.
  • 8 AstraZeneca, Gaithersburg, Maryland 20878, USA.
  • 9 The Genome Institute, Washington University, St Louis, Missouri 63110, USA.
  • 10 The Genome Institute, Washington University, St Louis, Missouri 63110, USA.
  • 11 Department of Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA.
  • 12 Division of Biostatistics, Washington University, St Louis, Missouri 63110, USA.
  • 13 Department of Pathology and Immunology, Washington University, St Louis, Missouri 63110, USA.
  • 14 1] Department of Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA [2] Siteman Cancer Center, Washington University, St Louis, Missouri 63110, USA.
  • 15 1] The Genome Institute, Washington University, St Louis, Missouri 63110, USA [2] Siteman Cancer Center, Washington University, St Louis, Missouri 63110, USA [3] Department of Genetics, Washington University, St Louis, Missouri 63110, USA.
  • 16 1] Department of Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA [2] Siteman Cancer Center, Washington University, St Louis, Missouri 63110, USA.
  • 17 1] Department of Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA [2] Siteman Cancer Center, Washington University, St Louis, Missouri 63110, USA.
  • 18 1] Department of Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA [2] Siteman Cancer Center, Washington University, St Louis, Missouri 63110, USA.
  • 19 1] Department of Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA [2] Siteman Cancer Center, Washington University, St Louis, Missouri 63110, USA.
  • 20 1] Department of Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA [2] Siteman Cancer Center, Washington University, St Louis, Missouri 63110, USA.
  • 21 Department of Pediatrics, Division of Hematology/Oncology, Washington University, St Louis, Missouri 63110, USA.
  • 22 1] Department of Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA [2] Siteman Cancer Center, Washington University, St Louis, Missouri 63110, USA.
  • 23 1] The Genome Institute, Washington University, St Louis, Missouri 63110, USA [2] Siteman Cancer Center, Washington University, St Louis, Missouri 63110, USA [3] Department of Genetics, Washington University, St Louis, Missouri 63110, USA.
Type
Published Article
Journal
Nature
1476-4687
Publisher
Nature Publishing Group
Publication Date
Volume
518
Issue
7540
Pages
552–555
Identifiers
DOI: 10.1038/nature13968
PMID: 25487151
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments